175 related articles for article (PubMed ID: 20332278)
21. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis.
Sun H; Kang EY; Chen H; Sweeney KJ; Suchko M; Wu Y; Wen J; Krishnamurthy S; Albarracin CT; Ding QQ; Foo WC; Sahin AA
Breast Cancer Res Treat; 2024 Jun; 205(2):403-411. PubMed ID: 38441847
[TBL] [Abstract][Full Text] [Related]
22. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.
Abubakar M; Howat WJ; Daley F; Zabaglo L; McDuffus LA; Blows F; Coulson P; Raza Ali H; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Tollenaar RA; Devilee P; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Wm Martens J; Hm van Deurzen C; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Broeks A; van Leeuwen FE; Van't Veer L; Swerdlow AJ; Orr N; Dowsett M; Easton D; Schmidt MK; Pharoah PD; Garcia-Closas M
J Pathol Clin Res; 2016 Jul; 2(3):138-53. PubMed ID: 27499923
[TBL] [Abstract][Full Text] [Related]
23. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
[TBL] [Abstract][Full Text] [Related]
24. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.
Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654
[TBL] [Abstract][Full Text] [Related]
25. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
[TBL] [Abstract][Full Text] [Related]
26. Proficiency testing of immunohistochemical biomarker assays in breast cancer.
Wasielewski Rv; Hasselmann S; Rüschoff J; Fisseler-Eckhoff A; Kreipe H
Virchows Arch; 2008 Dec; 453(6):537-43. PubMed ID: 18958494
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of estrogen receptor heterogeneity in breast cancer.
Chung GG; Zerkowski MP; Ghosh S; Camp RL; Rimm DL
Lab Invest; 2007 Jul; 87(7):662-9. PubMed ID: 17334408
[TBL] [Abstract][Full Text] [Related]
28. Computer Aided Semi-Automated Evaluation of HER2 Immunodetection--A Robust Solution for Supporting the Accuracy of Anti HER2 Therapy.
Micsik T; Kiszler G; Szabó D; Krecsák L; Hegedűs C; Tibor K; Molnár B
Pathol Oncol Res; 2015 Sep; 21(4):1005-11. PubMed ID: 25788005
[TBL] [Abstract][Full Text] [Related]
29. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
Marotti JD; Collins LC; Hu R; Tamimi RM
Mod Pathol; 2010 Feb; 23(2):197-204. PubMed ID: 19898422
[TBL] [Abstract][Full Text] [Related]
31. Use of automated image analysis in evaluation of Mesothelioma Tissue Microarray (TMA) from National Mesothelioma Virtual Bank.
Amin W; Srinivasan M; Song SY; Parwani AV; Becich MJ
Pathol Res Pract; 2014 Feb; 210(2):79-82. PubMed ID: 24359722
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
Laurinavicius A; Laurinaviciene A; Ostapenko V; Dasevicius D; Jarmalaite S; Lazutka J
Diagn Pathol; 2012 Mar; 7():27. PubMed ID: 22424533
[TBL] [Abstract][Full Text] [Related]
33. Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.
Helin HO; Tuominen VJ; Ylinen O; Helin HJ; Isola J
Virchows Arch; 2016 Feb; 468(2):191-8. PubMed ID: 26493985
[TBL] [Abstract][Full Text] [Related]
34. An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
Wesseling J; Tinterri C; Sapino A; Zanconati F; Lutke-Holzik M; Nguyen B; Deck KB; Querzoli P; Perin T; Giardina C; Seitz G; Guinebretière JM; Barone J; Dekker L; de Snoo F; Stork-Sloots L; Roepman P; Watanabe T; Cusumano P
Virchows Arch; 2016 Sep; 469(3):297-304. PubMed ID: 27377889
[TBL] [Abstract][Full Text] [Related]
35. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
[TBL] [Abstract][Full Text] [Related]
36. Soy consumption and histopathologic markers in breast tissue using tissue microarrays.
Maskarinec G; Erber E; Verheus M; Hernandez BY; Killeen J; Cashin S; Cline JM
Nutr Cancer; 2009; 61(5):708-16. PubMed ID: 19838945
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemistry scoring of breast tumor tissue microarrays: A comparison study across three software applications.
Baker GM; Bret-Mounet VC; Wang T; Veta M; Zheng H; Collins LC; Eliassen AH; Tamimi RM; Heng YJ
J Pathol Inform; 2022; 13():100118. PubMed ID: 36268097
[TBL] [Abstract][Full Text] [Related]
38. Image cytometric validation of breast carcinoma markers (ER, HER2 and MIB-1) using tissue microarrays: rabbit monoclonal vs. FDA-approved antibodies.
Nassar A; Norton CM; Lawson D; Cohen C
Anal Quant Cytol Histol; 2010 Aug; 32(4):192-200. PubMed ID: 21434519
[TBL] [Abstract][Full Text] [Related]
39. An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
Rimm DL; Leung SCY; McShane LM; Bai Y; Bane AL; Bartlett JMS; Bayani J; Chang MC; Dean M; Denkert C; Enwere EK; Galderisi C; Gholap A; Hugh JC; Jadhav A; Kornaga EN; Laurinavicius A; Levenson R; Lima J; Miller K; Pantanowitz L; Piper T; Ruan J; Srinivasan M; Virk S; Wu Y; Yang H; Hayes DF; Nielsen TO; Dowsett M
Mod Pathol; 2019 Jan; 32(1):59-69. PubMed ID: 30143750
[TBL] [Abstract][Full Text] [Related]
40. ER and PR immunohistochemistry and HER2 FISH versus oncotype DX: implications for breast cancer treatment.
Park MM; Ebel JJ; Zhao W; Zynger DL
Breast J; 2014; 20(1):37-45. PubMed ID: 24261318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
